Cyclooxygenase-2 (COX-2) inhibitors have long been employed to modulate inflammatory responses in a range of conditions, from arthritis to malignancies. In recent years, the convergence of ...
Over the past five years, selective cyclooxygenase-2 inhibitors (coxibs) have accounted for a growing proportion of prescriptions for nonsteroidal antiinflammatory drugs (NSAIDs). To control these ...
The results of the clinical trial by Smith et al 1 confirm that celecoxib does seem to inhibit rising PSA levels in men who have undergone treatment for prostate cancer. Questions still remain as to ...
Purpose: A summary of the basic science underlying the current controversies regarding cyclooxygenase-2 (COX-2)-selective nonsteroidal antiinflammatory drugs (NSAIDs), including data on their ...
To the Editor: The review article by FitzGerald and Patrono (Aug. 9 issue) 1 on the coxibs, selective inhibitors of cyclooxygenase-2 (COX-2), included a table listing pharmacokinetic and metabolic ...
Phase III Trial Comparing Radical Radiotherapy With and Without Cisplatin Chemotherapy in Patients With Advanced Squamous Cell Cancer of the Cervix PURPOSE: To investigate the expression of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results